In patients with HAM, markers of inflammation (CXCL10 and neopterin) and neuronal damage (Nf-L) increased according to the degree of walking impairment being highest in wheelchair-dependent patients (Figure 1, D–F). The gene discussed is CXCL10; the disease is tropical spastic paraparesis.